FLASHPOINT-VC
31.10.2023 10:28:29 CET | Business Wire | Press release
Flashpoint announces its partnership with renowned growth investor, Roman Ivaniuk through the establishment of a joint venture fund to invest in direct secondary opportunities in growth stage companies in Europe.
Flashpoint is an international tech investment manager with over $400 million AUM focused on tech companies originating from Europe and Israel. Roman Ivaniuk is an investment banker with 12+ years of experience, 50+ closed deals (VC, PE, pre-IPO, IPO), and $1B+ total closed deals value. He is a Founder and former MP of GR Capital (a Pan-European venture fund), the current Founder and MP of an investment company BrightOne Capital.
The fund’s strategy will be to support prominent growth-stage tech companies in Europe through investments in direct secondary opportunities. The unique synergy of this partnership will be directed towards raising $150 million, with an initial $50 million for the first closing. The partners have been present in the EU/Israel VC ecosystem for 10+ years. They established direct relationships with founders and investors alike, giving them unique insights into market trends and access to exclusive deal flow.
Flashpoint made 13 primary investments into growth-stage companies within its portfolio of 47 active investments. This is the second Flashpoint fund investing in direct secondaries: the predecessor, Flashpoint Secondary Fund I (“FSF I”), was launched in 2020 and was anchored by the Scheinberg family office. The current portfolio of FSF I consists of 6 later-stage companies, including K2View, Printify, Preply, Mesh Payments, Booksy, and Landtech.
Roman Ivaniuk’s track record covers investments in WeFox, McMackler, Glovo, Deliveroo, Sennder, Azimo and Flashcenpost among others. There were 10 successful exits in his portfolio in 2016-2021. He also has a strong private equity experience in Ukraine, having developed the country’s largest healthcare chain Dobrotut.
Flashpoint, led by Alex Konoplyasty, Michael Szalontay, and Igor Bilous, is renowned for its strategic investments in innovative technology startups originating from Emerging Europe and Israel. Flashpoint manages five funds: 3 VC funds, 1 Growth Debt Fund, and 1 Direct Secondaries Fund. Investors in Flashpoint’s funds include more than 130 major family offices and HNWIs. The funds have made investments in over 66 companies including Guesty, Chili Piper, and Office RnD. Flashpoint has completed fifteen exits, including the sale of its stakes in Shazam (to Apple), Chess.com (to PokerStars founders and General Atlantic), Marketman (to PSG), and Gurushots (to Zedge), Comeet (to Boathouse Capital), etc.
Currently, Roman is focused on late-stage VC and Growth investments in the EU/UK, on globalization and expansion of profitable companies with Ukrainian roots, cross-border transactions, and international fundraising.
Michael Szalontay, General Partner at Flashpoint, said: “We are delighted to announce our partnership with Roman Ivaniuk on this innovative joint venture fund. Together, we can combine our substantial networks and track records across CEE and Israel to deliver significant value and expertise to investors and investees alike. We are excited about our prospects as we pursue our goal of raising $150 million which we will allocate to some of the world’s most exciting growth stories.”
Roman Ivaniuk, Managing Partner at Flashpoint RI Secondary Fund II, said: “This joint venture is an extension of our successful investments in the EU tech companies with their further expansion. Flashpoint VC has a strong CEE base and a great VC track record. I helped to globalize my portfolio of growth companies in the CEE region and know every step from the inside. Together we have a cool overlap and unique strategy. Our expertise and direct access to the companies is a great value for our Secondary Fund. I feel confidence and excitement toward our new joint venture and our future investment opportunities.”
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231031982284/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom